Homologous Recombination Deficiency
specific5
Centers
1
Active Trials
$20M
Cancer Funding
Top Centers for Homologous Recombination Deficiency(5)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 69.5 |
| 2 | NCI Comprehensive Active Research Program | 64.0 |
| 3 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 62.5 |
| 4 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 55.5 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 48.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →